Document is current

Article History

Received: 22 June 2021

Accepted: 27 September 2021

First Online: 26 October 2021

Declarations

:

: Dr. Karaca-Mandic serves as the principal investigator to the grant that funded this study (Agency for Healthcare Research and Quality, R01 HS025164, PI: Karaca-Mandic). She reports funding from AHRQ (this grant), the American Cancer Society, the NIHCM Foundation, and the National Institute on Drug Abuse as well as consulting fees from Tactile Medical, Precision Health Economics, and Sempre Health for unrelated work. Dr. Jeffery reports funding from AHRQ (this grant) and from the American Cancer Society, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, and the US Food and Drug Administration for unrelated work. Dr. Duarte Garcia reports funding from the Centers for Disease Control and Prevention and from the Rheumatology Research Foundation. Mr. Levin and Ms. Chang are graduate students in the Division of Health Policy and Management, University of Minnesota School of Public Health. Ms. Chang is also an employee at the Health Care Cost Institute for work unrelated to this manuscript.